Ascendance Biotechnology ascendancebio.com


Public lists: Pharma Startups (6570)

Ascendance Biotechnology is was formed by BioTime and Hepregen Corporation to address the In Vitro cell biology market. Ascendance combines Hepregen's application-directed, cellular micro-patterning drug and chemical screening technologies with BioTime's ESI BIO research products and proprietary stem cell technologies. This asset combination will allow Ascendance to offer a broad portfolio of current and new stem-cell-derived assays and other products and services to Hepregen's major pharmaceuti...Show all

Ascendance Biotechnology is was formed by BioTime and Hepregen Corporation to address the In Vitro cell biology market. Ascendance combines Hepregen's application-directed, cellular micro-patterning drug and chemical screening technologies with BioTi...Show all

Company (Acquired)

All investors data 3 Investors

Phone: 781-391-0205

Fax:

200 Boston Avenue
Suite 1500
 Medford, 02155
 Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Ascendance Biotechnology $0.9M Mar 27, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Ascendance Biotechnology Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Systems and methods for canine liver modeling Jan 26, 2016 Jun 30, 2020 Patent